Nipro Co. (OTCMKTS:NPRRF) Sees Significant Drop in Short Interest

Nipro Co. (OTCMKTS:NPRRFGet Free Report) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totaling 49,916 shares, a decline of 61.6% from the May 31st total of 129,972 shares. Based on an average daily volume of 1 shares, the short-interest ratio is presently 49,916.0 days.

Nipro Stock Performance

Shares of NPRRF stock opened at $9.96 on Friday. The business’s 50 day moving average is $9.96 and its two-hundred day moving average is $9.22. Nipro has a 12-month low of $9.67 and a 12-month high of $9.96.

About Nipro

(Get Free Report)

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. The company's Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services.

Recommended Stories

Receive News & Ratings for Nipro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nipro and related companies with MarketBeat.com's FREE daily email newsletter.